Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Twist Bioscience Corp (TWST)

274 + Investors. Track Smart Money conviction in TWST. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +34
Streak
2Q ▲
Buyers last Q
54%

Smart Money Signals — TWST

Based on 275 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added TWST than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
275 hedge funds hold TWST right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+18 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

144 buying121 selling
Last quarter: 144 funds bought or added vs 121 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter
Funds opening a new TWST position: 35 → 34 → 54 → 69. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

56% of holders stayed for 2+ years

56% conviction (2yr+) 19% medium 25% new
154 out of 275 hedge funds have held TWST for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +50% but shares only +2% — price-driven

Value
+49%
Shares
+2%
Last quarter: the total dollar value of institutional holdings rose +50%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

48 → 35 → 34 → 54 → 69 new funds/Q
New funds entering each quarter: 35 → 34 → 54 → 69. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 62% veterans vs 27% newcomers

62% veterans 11% 1-2yr 27% new
Entry-cohort mix of 281 holders: 175 (62%) are 2+ year veterans, 30 entered 1–2 years ago, and 76 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
54 of 275 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TWST

In 2026 Q1, 144 hedge funds were net buyers of TWST (69 opened a new position, 75 added to an existing one), while 121 reduced or exited (86 trimmed, 35 sold completely) — a 54% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 32% of total institutional value in TWST is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +34 funds (more new holders than closures). Total institutional holders: 275.

Hedge Fund Ownership: TWST

How many hedge funds hold TWST — quarterly history vs. share price
Quarterly hedge fund ownership of TWST vs. share price

Market Analysis: TWST

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TWST

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Twist Bioscience Corp (TWST) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TWST has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
TWST
+73.2%
XLV
+4.5%

TWST outperformed XLV by +68.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
TWST
+67.4%
XLV
+5.6%

Since the filing became public, TWST outperformed XLV by +61.8% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

32 top-rated funds 4 high-conviction
Consensus
6.6
/ 10
breadth
×
Elite
3.9
/ 10
conviction
Hedge Fund Positioning: TWST
274 + Investors

Track Smart Money conviction in TWST. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 274 241 13.69%
13F Shares 77M 75M 2.36%
Total Value $3.58B $2.39B 49.7%
New Positions 68 54 +14
Increased Positions 75 72 +3
Closed Positions 35 43 -8
Reduced Positions 85 77 +8
Total Calls 3 5 -40.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.0 0.6 Neutral

Statistics: TWST

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

274 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TWST. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TWST holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Tao Capital Management LP 33.14% 828,815 $39.4M
2 Blue Water Life Science Advisors, LP 10.52% 276,000 $13.1M
3 Freshford Capital Management, LLC 6.15% 258,982 $12.3M
4 First Light Asset Management, LLC 3.74% 878,848 $41.8M
5 Semanteon Capital Management, LP 2.81% 4,400 $209K
6 Soleus Capital Management, L.P. 2.36% 1,226,629 $58.3M
7 ARK Investment Management LLC 2.34% 6,342,733 $301.4M
8 EdgePoint Investment Group Inc. 2.05% 5,382,521 $255.8M
9 Metavasi Capital LP 1.72% 100,000 $4.8M
10 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 1.03% 284,589 $13.5M
11 Amova Asset Management Americas, Inc. 1.01% 1,496,099 $71.1M
12 William Blair Investment Management, LLC 0.83% 5,269,718 $250.4M
13 HighMark Wealth Management LLC 0.76% 39,290 $1.9M
14 Meridiem Capital Partners LP 0.74% 239,669 $11.4M
15 Brandywine Managers, LLC 0.59% 20,970 $996K
16 Arrowpoint Investment Partners (Singapore) Pte. Ltd. 0.57% 13,476 $640K
17 Osterweis Capital Management Inc 0.52% 211,158 $10.0M
18 Artisan Partners Limited Partnership 0.49% 6,367,777 $302.6M
19 Odyssean, LLC 0.46% 26,232 $1.2M
20 Stempoint Capital LP 0.40% 43,110 $2.0M
21 Peregrine Capital Management LLC 0.39% 220,079 $10.5M
22 Farallon Capital Management LLC 0.39% 1,427,650 $67.8M
23 Strategic Advocates LLC 0.37% 1,760 $84K
24 Oddo Bhf Asset Management Sas 0.27% 145,960 $6.9M
25 Green Alpha Advisors, LLC 0.25% 5,303 $252K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Twist Bioscience Corp (TWST)

What does the Smart Money Trend signal show for TWST?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added TWST than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TWST?

Slight buying edge — 54% buying: Last quarter: 144 funds bought or added vs 121 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TWST holders?

Strong quality — 32% AUM from major funds: 54 of 275 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TWST?

56% of holders stayed for 2+ years: 154 out of 275 hedge funds have held TWST for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Twist Bioscience Corp (TWST) following the 2026 Q1 hedge fund 13F filings?

As of today, TWST has moved +67.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.6% for the XLV sector ETF — an outperformance of +61.8%. Since the quarter end (March 31, 2026), TWST has gained +73.2% vs +4.5% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →